TP53 and gastric cancer: Furthermore, binding of cyclin E and cyclin-dependent kinase 2 promotes the transition of the cell cycle from stage G1 to stage S. The prognosis of GC patients positive for cyclin E is poor; combining cyclin E overexpression with p53 expression was able to differentiate patients with poor prognosis [17, 18].